Key Considerations for your Gene Therapy Product Launch
Throughout this webinar our experts and client guest speaker, Ian Mussen, Head of Supply Chain EMEA, Novartis Gene Therapies will share valuable insight into the key considerations for a successful Gene Therapy product launch.
The presenters will review areas such as developing bespoke packaging processes to facilitate in most cases, Ultra Low Temperature handling requirements and the various Just in Time supply chain models. Ian will join the Almac team to share his real-life experience of successfully launching Zolgensma onto the EU market including the approach Novartis Gene Therapies took to ensure a smooth launch and what lessons were learnt along the way.
Thursday 17th June, 3pm BST
Speakers: Robert O’Brien, Head of Technical Support and Ian Mussen, Head of Supply Chain EMEA, Novartis Gene Therapies
Head of Technical Support
Robert has almost 20 years’ experience in managing commercial product launches in both pharmaceutical and FMCG industries. Over this period, he has led multi-disciplinary teams to support a number of challenging, but ultimately, successful, global product launches and transition into on-going commercial supply. Leading the Technical Support function within Almac Commercial Packaging, he and his team are responsible for end-to-end operational launch. From product & process design, through validation requirements to timely commercial production and launch.
After graduating from University of Liverpool, Robert spent the majority of his career in the soft drink industry working for both Coca-Cola and Britvic plc on national and international developments and product launches, before transferring to pharmaceuticals.